Shanghai Junshi Biosciences Co.Ltd(688180) : js113 drug clinical trial application accepted

April 1, 2022

Shanghai Junshi Biosciences Co.Ltd(688180) ( Shanghai Junshi Biosciences Co.Ltd(688180) ) announced on April 1 that the holding subsidiary Suzhou JunJing biomedicine received the acceptance notice approved and issued by the State Food and drug administration, and the clinical trial application of the fourth generation EGFR inhibitor wj13404 tablets (project code "js113") was accepted.

- Advertisment -

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

Shanghai Junshi Biosciences Co.Ltd(688180) : js113 drug clinical trial application accepted

Tiantu investment starts H-share IPO: the proportion of self owned capital investment is r...

Shenzhen L&A Design Holding Limited(300949) : AoYa blooming digital art museum will b...

Chongqing Sokon Industry Group Stock Co.Ltd(601127) : the fixed increase of RMB 7.13 billi...

Shandong Chenming Paper Holdings Limited(000488) : Notice on convening the first extraordi...

Shandong Chenming Paper Holdings Limited(000488) : statement of independent director Nomin...

East China Engineering Science And Technology Co.Ltd(002140) : East China Engineering Sc...

Shandong Chenming Paper Holdings Limited(000488) : announcement of the resolution of the 2...

Shandong Chenming Paper Holdings Limited(000488) : statement of independent director Nomin...

East China Engineering Science And Technology Co.Ltd(002140) : independent opinions of ind...

Shandong Chenming Paper Holdings Limited(000488) : statement of independent director Nomin...

East China Engineering Science And Technology Co.Ltd(002140) : East China Engineering Sc...